Hepatitis B Virus Infection After Liver Transplantation in Children

Status Recruiting

Clinical Trial Summary

China is a highly prevalent area of hepatitis B virus（HBV） infection, with at least 75 million hepatitis B virus carriers, and 80% of primary hepatocellular carcinoma (HCC) is associated with chronic hepatitis B virus infection. Liver transplantation is currently the preferred method for end-stage liver disease such as biliary atresia and cirrhosis in children. In recent years, children's liver transplantation has developed rapidly and the number of developments has increased significantly. If there is chronic hepatitis B virus infection in the donor liver, it may cause HBV transmission, or the patient may have a low-load occult hepatitis B virus infection, and after immunosuppressive treatment, it may lead to hepatitis B virus infection after surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03865966
Study type	Observational
Source	Children's Hospital of Chongqing Medical University
Contact	Yao Zhao
Phone	+862363603083
Email	Zhaoy@cqmu.edu.cn
Status	Recruiting
Phase
Start date	July 5, 2019
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04704024` - Reducing Vertical Transmission of Hepatitis B in Africa	Phase 3
Active, not recruiting	`NCT02143401` - Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors	Phase 1
Completed	`NCT00371150` - Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection	Phase 4
Active, not recruiting	`NCT03519113` - HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102	Phase 2/Phase 3
Completed	`NCT01788371` - Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus	Phase 4
Recruiting	`NCT06368479` - Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings	N/A
Completed	`NCT01488526` - Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus	Phase 4
Terminated	`NCT02826018` - A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection	Phase 1
Completed	`NCT01970254` - Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
Completed	`NCT00489099` - A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)	Phase 3
Recruiting	`NCT03476083` - Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission	Phase 4
Completed	`NCT03627507` - Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.	Phase 2/Phase 3
Completed	`NCT02443233` - Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong	N/A
Completed	`NCT00841477` - An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users	Phase 3
Terminated	`NCT03887702` - Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors	Phase 3
Completed	`NCT02304315` - A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients	Phase 2
Active, not recruiting	`NCT05117541` - Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
Not yet recruiting	`NCT06368466` - A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites	N/A